Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
Shiba Inu’s key on-chain metric has dropped to a five-year low, signaling caution but also a possible setup for a fut...
Dell fell about 6% as memory costs squeezed margins, while Western Digital rose around 5% on continued AI-driven dema...
Ford faces renewed scrutiny as recalls mount and U.S. sales soften, fueling a debate over whether ford should give ba...
Moonshot AI unveils Kimi K3, a new open Chinese AI model that could alter the competitive balance in the AI race. Inv...
Rumors swirl about Prince Andrew facing arrest in a public-office misconduct probe. This report examines his estimate...
Anthropic’s safety-first AI stance is colliding with government pressure, placing its investors in a pivotal role as ...
The question on many investors' minds is clear: is it too late to buy Ethereum in 2026? This article breaks down the ...
Memory chips are fueling a renewed AI stock rally, but Harvard’s Willy Shih cautions that the boom could cool. Here’s...
Pi Network’s PI moved back above $0.15 as upbeat developments from OKX and a broader altcoin rally lift sentiment. In...
Outpoll launches a global prediction market platform, bringing professional tools and API access to a mainstream audi...